Tumor Necrosis Factor-Mediated Survival of CD169 Cells Promotes Immune Activation During Vesicular Stomatitis Virus Infection

Innate immune activation is essential to mount an effective antiviral response and to prime adaptive immunity. Although a crucial role of CD169 cells during vesicular stomatitis virus (VSV) infections is increasingly recognized, factors regulating CD169 cells during viral infections remain unclear. Here, we show that tumor necrosis factor is produced by CD11b Ly6C Ly6G cells following infection with VSV. The absence of TNF or TNF receptor 1 (TNFR1) resulted in reduced numbers of CD169 cells and in reduced type I interferon (IFN-I) production during VSV infection, with a severe disease outcome. Specifically, TNF triggered RelA translocation into the nuclei of CD169 cells; this translocation was inhibited when the paracaspase MALT-1 was absent. Consequently, MALT1 deficiency resulted in reduced VSV replication, defective innate immune activation, and development of severe disease. These findings indicate that TNF mediates the maintenance of CD169 cells and innate and adaptive immune activation during VSV infection. Over the last decade, strategically placed CD169 metallophilic macrophages in the marginal zone of the murine spleen and lymph nodes (LN) have been shown to play a very important role in host defense against viral pathogens. CD169 macrophages have been shown to activate innate and adaptive immunity via "enforced virus replication," a controlled amplification of virus particles. However, the factors regulating the CD169 macrophages remain to be studied. In this paper, we show that after vesicular stomatitis virus infection, phagocytes produce tumor necrosis factor (TNF), which signals via TNFR1, and promote enforced virus replication in CD169 macrophages. Consequently, lack of TNF or TNFR1 resulted in defective immune activation and VSV clearance.